The efficacy and safety of PARP inhibitors in mCRPC with HRR mutation in second-line treatment: a systematic review and bayesian network meta-analysis
Article in BMC Cancer (June 2024)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Article in BMC Cancer (June 2024)
Article in Oncogene (May 2024)
Article in Clinical and Translational Oncology (May 2024)